DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALS

被引:67
作者
MAAS, JW [1 ]
HATTOX, SE [1 ]
MARTIN, DM [1 ]
LANDIS, DH [1 ]
机构
[1] YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA
关键词
D O I
10.1111/j.1471-4159.1979.tb04568.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abstract— A direct method for measuring the rate of dopamine (DA) synthesis and the DA metabolites by the brain of awake monkeys (Macaca arctoides) is described. The method utilizes a coupling of a measure of cerebral blood flow with the mass spectrometrically determined difference in the concentrations of the metabolite under study in plasma obtained from arterial and internal jugular bulb blood. For homovanillic acid (HVA) a consistent and highly significant veno‐arterial (V‐A) difference of 2.2 ± 0.4 ng/ml of plasma (P < 0.0005) was found. When this V‐A difference was coupled with a measure of cerebral blood flow it was determined that, in the awake monkey, the average output of HVA by brain was 113.4 ± 19.1ng/100g brain min−1. There were large individual variations, however, between animals (range = 38‐194 ng/100g brain min−1). In contrast to HVA, no consistent V‐A difference for dihydroxyphenylacetic acid (DOPAC) was found; i.e. the concentrations of DOPAC in plasma obtained from arterial and internal jugular bulb venous blood were essentially identical. These data indicate that, in contrast to the rat, in this non‐human primate HVA is the major metabolic product of brain DA. Since HVA is the major metabolite of DA, production of HVA under steady state conditions gives a measure of DA synthesis by whole brain; i.e. the rate of DA synthesis by whole brain in the awake monkey is 113.4 ± 19.1ng/100g brain min−1. It is suggested that this technique may be of value in both basic and applied types of studies. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:839 / 843
页数:5
相关论文
共 25 条
[1]   FURTHER EVIDENCE FOR PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN RAT [J].
ANDEN, NE ;
DAHLSTROEM, A ;
FUXE, K ;
LARSSON, K .
AMERICAN JOURNAL OF ANATOMY, 1965, 116 (01) :329-+
[2]   DRUGS AFFECTING MOVEMENT DISORDERS [J].
BARBEAU, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 :91-113
[3]  
BESSON MJ, 1971, J PHARMACOL EXP THER, V177, P196
[4]  
BIEGER D, 1976, CHEM TRANSMISSION MA, P215
[5]   CATECHOLAMINES IN NEOCORTEX OF RHESUS-MONKEYS - REGIONAL DISTRIBUTION AND ONTOGENETIC DEVELOPMENT [J].
BROWN, RM ;
GOLDMAN, PS .
BRAIN RESEARCH, 1977, 124 (03) :576-580
[6]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[7]  
CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[8]  
COSTA E, 1966, BIOCHEMISTRY PHARMAC, P141
[10]   DIHYDROXYPHENYLACETIC ACID CONJUGATE - NATURAL OCCURRENCE AND DEMONSTRATION OF PROBENECID-INDUCED ACCUMULATION IN RAT STRIATUM, OLFACTORY TUBERCLES AND FRONTAL CORTEX [J].
ELCHISAK, MA ;
MAAS, JW ;
ROTH, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (04) :369-378